-
Jiang Sanqiao, deputy general manager of Bank of Quantum Hi-Tech, plans to reduce its holdings by no more than 90,000
Time of Update: 2021-11-03
According to the announcement, Jiangsanqiao currently holds approximately 363,900 shares of Quan Yin Hi-Tech, accounting for 0.
0817% of the company's total share capital after excluding the number of shares in the special repurchase account .
-
Longping Hi-Tech's application for fixed increase has not been approved by the China Securities Regulatory Commission
Time of Update: 2021-09-12
On the evening of September 6, Longping Hi-Tech, a seed company, issued an announcement showing that the issuance review committee of the China Securities Regulatory Commission reviewed its application for non-public issuance of shares, but it failed to pass the review .
-
Affected by the epidemic, Brazil's per capita beef consumption fell to its lowest level in the past 25 years
Time of Update: 2021-08-01
Brazil's epidemic beef slaughtering Chinese imports Researchers from the beef department of the Brazilian Institute of Agriculture and Animal Husbandry (Embrapa) believe that the new crown epidemic is the main culprit for unemployment and reduced income.
-
On the second trading day of listing, Shennong Group fell to its intraday limit
Time of Update: 2021-06-22
On May 31, the Yunnan pig company Shennong Group, which was listed on the A-share market for only 2 trading days, dropped its limit during the intraday trading.
On May 31, on the second trading day of the listing, Shennong Group opened low, with an intraday limit.
-
Hidden dangers of IPO outbreak in the biotechnology market in the first quarter of 2021 still exist
Time of Update: 2021-04-24
Judging from the IPO data from the beginning of 2021 to the present, private biopharmaceutical companies who are worried about missing listing opportunities can rest assured, because the first quarter of this year, both in terms of the number of listings and the amount of financing, are huge, indicating that market opportunities are still open.
-
Epichlorohydrin Daily: Weakness does not change
Time of Update: 2021-04-05
On the trading day (December 20, 2012), the epichlorohydrin raw material market was confronted with longs and shorts, focusing on sorting: (omitted, see the full version for details).
-
China Resources Shuanghe acquired Xiangzhong Pharmaceuticals to take an 80% share of the region
Time of Update: 2021-02-28
June 4, China Resources Shuanghe announced that it will use its own funds to acquire a 40% stake in China Resources Shuanghe Limin Pharmaceuticals (Jinan) Co., Ltd. for 847.66 million yuan.
-
The international sugar price "slashes" Costa Rica's sugarcane industry within six months is facing challenges
Time of Update: 2021-01-11
The Costa Rican Sugar Cane Industry Alliance (Liga Agrícola Industrial de la Caña de Azúcar) said recently that high sugar production in India and Pakistan had saturation the market and that international sugar prices had fallen by 53% in a year and a half.
-
Ministry of Agriculture and Rural Affairs: Corn prices will be limited, but soybeans will remain high
Time of Update: 2021-01-03
1, pig prices after a small rise is expected to stabilize the Ministry of Agriculture and Rural Market and Information Technology Director Tang Wei: pig production capacity continued to recover, pork prices fell for three consecutive months, the recent demand-led small rebound.
-
Sixty-six polyester factories have entered the Spring Festival overhaul
Time of Update: 2020-11-23
According to statistics, with last week's mainstream polyester plant after many days of hot production and sales, the current polyester factory inventory is also showing a sharp decline in the situation, inventory average in 10 days, down 5-6 days from the last week, of which POY inventory remained at 7 days, FDY inventory remained at 11 days, DTY inventory in 13 days, has basically returned to the same period last year inventory level.
-
1.775 billion! Domestic cardiovascular industry leading enterprises by Carlyle brand
Time of Update: 2020-11-18
In addition, in the first half of 2020, the company's heart failure-resistant JK07 Sino-American double report is conducting Phase I clinical trials in the United States; In the industry's view, China's pharmaceutical market is entering a sustained and stable long-term growth cycle as society ages and consumption levels rise, health awareness increases, and biotechnology continues to innovate.
-
Innovent announces preliminary results of phase I clinical study of anti-CTLA-4 monoclonal antibody IBI310
Time of Update: 2020-06-27
Guide: IBI310 is recombinant whole human-derived anticellular T lymphocyte-related antigen 4 (CTLA-4) monoclonal antibody antibody, by increasing the human effect T-cell-mediated anti-tumor immune res
-
Probe into the current situation of unprofitable pharmaceutical enterprises listed in Hong Kong
Time of Update: 2019-12-12
Obviously, the purpose of the policy dividend for unprofitable drug companies is to broaden the financing channels of innovative drug companies and to help the R & D and commercialization of new drug companies Now, more than a year after the opening of Hong Kong stock market, what are the performances of these listed unprofitable pharmaceutical companies?
-
Beidujia pharmaceutical industry has applied for delisting decision due to twists and turns in the way of resumption
Time of Update: 2019-11-25
[industry trends of pharmaceutical network] Beidou Jia pharmaceutical recently announced that the company received a letter from the stock exchange on November 15, 2019, indicating that the trading of
-
Great news! Baiji Shenzhou announced the establishment of a global cancer strategic partnership with Amgen
Time of Update: 2019-11-01
November 1, 2019 / BIOON / -- Baiji Shenzhou (NASDAQ (8292.3602, - 11.62, - 0.14%) code: bgne; Hong Kong stock exchange code: 06160) and Amgen (NASDAQ Code: AMGN) today announced a global cancer strat
